Pegfilgrastim (KRN125)

pegfilgrastim · Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegfilgrastim (KRN125), covering 2017-03-03 to 2017-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients [Phase 2]